Pathologists are leveraging data in ways that truly advance the promise of precision medicine. The evolution of the term precision medicine was a direct reflection in the progression in clinical ...
First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...
SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces ...
SAN ANTONIO, January 07, 2026--bioAffinity's laboratory, Precision Pathology Laboratory Services, maintains accreditation from the College of American Pathologists ...
bioAffinity Technologies, Inc. ( (BIAF)) has provided an announcement. On September 18, 2023, bioAffinity Technologies’ subsidiary Precision Pathology Laboratory Services consummated the acquisition ...
The Treating Obesity with Precision Lab conducts research to individualize the diagnosis and treatment of obesity and diabetes. The lab has three main areas of research: Investigating the role of ...
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath Pathology Services, Inc., Peninsula Pathology Medical Group (PPMG), ...
PathAI, Inc., a leading AI-powered precision pathology company, today announced an expanded and exclusive relationship with Roche Tissue Diagnostics (RTD) that will bring AI-enabled interpretation to ...
Human tissue samples were retrieved from the files of the Division of Pathology, The Hospital for Sick Children. The samples of normal, control small intestine mucosa included duodenal biopsies from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback